The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma

References

• Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.
   PubMedGoogle Scholar
• Sanabria A, Kowalski LP, Shah JP, et al. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck. 2018;40:855–866.
   PubMed Web of Science ®Google Scholar
• Noone AM, Cronin KA, Altekruse SF, et al. Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992-2013. Cancer Epidemiol Biomarkers Prev. 2017;26:632–641.
   PubMed Web of Science ®Google Scholar
• Sak SD. Variants of papillary thyroid carcinoma: multiple faces of a familiar tumor. Turk Patoloji Derg. 2015;31:34–47.
   PubMedGoogle Scholar
• Liu Y, Su L, Xiao H. Review of factors related to the thyroid cancer epidemic. Int J Endocrinol. 2017;2017:5308635.
   PubMed Web of Science ®Google Scholar
• Heidari Z, Mohammadpour-Gharehbagh A, Eskandari M, et al. Genetic polymorphisms of miRNA let7a-2 and pri-mir-34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features. J Cell Biochem. 2018.
   Web of Science ®Google Scholar
• Mohammadpour-Gharehbagh A, Heidari Z, Eskandari M, et al. Association between genetic polymorphisms in microRNA machinery genes and risk of papillary thyroid carcinoma. Pathol Oncol Res. 2019;1–7.
   PubMed Web of Science ®Google Scholar
• de Morais RM, Sobrinho AB, de Souza Silva CM, et al. The role of the NIS (SLC5A5) gene in papillary thyroid cancer: a systematic review. Int J Endocrinol. 2018;2018:9128754.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
   PubMed Web of Science ®Google Scholar
• Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.
   PubMed Web of Science ®Google Scholar
• Zhivotovsky B, Cotter T. Caspases: the enzymes of death. Essays Biochem. 2003;39:25–40.
   PubMed Web of Science ®Google Scholar
• Brentnall M, Rodriguez-Menocal L, De Guevara RL, et al. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013;14:32.
   PubMed Web of Science ®Google Scholar
• Olsson M, Zhivotovsky B. Caspases and cancer. Cell Death Differ. 2011;18:1441–1449.
   PubMed Web of Science ®Google Scholar
• Huang KH, Fang WL, Li AF, et al. Caspase-3, a key apoptotic protein, as a prognostic marker in gastric cancer after curative surgery. Int J Surg. 2018;52:258–263.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhong DN, Qin H, et al. Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases. Oncotarget. 2018;9:8629–8641.
   PubMedGoogle Scholar
• Li B, Liu H, Gong F, et al. Molecular epidemiologic correlation analysis between caspase3 gene polymorphism and gastric cancer susceptibility. Cell Biochem Biophys. 2014;70:1647–1653.
   PubMed Web of Science ®Google Scholar
• Soung YH, Lee JW, Kim SY, et al. Somatic mutations of CASP3 gene in human cancers. Hum Genet. 2004;115:112–115.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Moazeni-Roodi A, Ghavami S. Association between CASP3 polymorphisms and overall cancer risk: a meta-analysis of case-control studies. J Cell Biochem. 2018.
   Web of Science ®Google Scholar
• Teimoori B, Yazdi A, Rezaei M, et al. The association of the placental CASPASE-3 gene polymorphisms and preeclampsia susceptibility and in-silico analysis. J Cell Biochem. 2018;119:6756–6764.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yu X, Guo Y, et al. Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma. Cancer Sci. 2012;103:555–560.
   PubMed Web of Science ®Google Scholar
• Sankari SL, Masthan KM, Babu NA, et al. Apoptosis in cancer–an update. Asian Pac J Cancer Prev. 2012;13:4873–4878.
   PubMed Web of Science ®Google Scholar
• Winter E, Chiaradia LD, Silva AH, et al. Involvement of extrinsic and intrinsic apoptotic pathways together with endoplasmic reticulum stress in cell death induced by naphthylchalcones in a leukemic cell line: advantages of multi-target action. Toxicol In Vitro. 2014;28:769–777.
   PubMed Web of Science ®Google Scholar
• Plati J, Bucur O, Khosravi-Far R. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities. J Cell Biochem. 2008;104:1124–1149.
   PubMed Web of Science ®Google Scholar
• Hassan M, Watari H, AbuAlmaaty A, et al. Apoptosis and molecular targeting therapy in cancer. Biomed Res Int. 2014;2014:150845.
   PubMed Web of Science ®Google Scholar
• Zhao R, Kaakati R, Lee AK, et al. Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond. Cancer Metastasis Rev. 2018;37:227–236.
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen XY, Liu J, et al. Differential caspase-3 expression in noncancerous, premalignant and cancer tissues of stomach and its clinical implication. Cancer Detect Prev. 2006;30:168–173.
   PubMedGoogle Scholar
• Winter RN, Kramer A, Borkowski A, et al. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res. 2001;61:1227–1232.
   PubMed Web of Science ®Google Scholar
• Nassar A, Lawson D, Cotsonis G, et al. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome. Appl Immunohistochem Mol Morphol. 2008;16:113–120.
   PubMedGoogle Scholar
• Flanagan L, Meyer M, Fay J, et al. Low levels of caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: caspase-3 inhibition as a therapeutic approach. Cell Death Dis. 2016;7:e2087.
   PubMed Web of Science ®Google Scholar
• Jin S-J, Yang Y, Ma L, et al. In vivo and in vitro induction of the apoptotic effects of oxysophoridine on colorectal cancer cells via the Bcl-2/Bax/caspase-3 signaling pathway. Oncol Lett. 2017;14:8000–8006.
   PubMed Web of Science ®Google Scholar
• Ujvari B, Klaassen M, Raven N, et al. Genetic diversity, inbreeding and cancer. Proc Biol Sci. 2018;285:1875.
   Web of Science ®Google Scholar
• Mittal RD, Srivastava P, Mittal T, et al. Association of death receptor 4, caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians. Eur J Surg Oncol. 2011;37:727–733.
   PubMed Web of Science ®Google Scholar
• Mittal RD, Mittal T, Singh AK, et al. Association of caspases with an increased prostate cancer risk in North Indian population. DNA Cell Biol. 2012;31:67–73.
   PubMed Web of Science ®Google Scholar
• Lin J, Zhang Y, Wang H, et al. Genetic polymorphisms in the apoptosis-associated gene CASP3 and the risk of lung cancer in Chinese population. Plos One. 2016;11:e0164358.
   PubMedGoogle Scholar
• Chen K, Zhao H, Hu Z, et al. Polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008;14:6343–6349.
   PubMed Web of Science ®Google Scholar
• Lopez-Trigo N, Aguin N, Castuera IP, et al. Association of CASP3 genetic polymorphisms rs1049216, rs2705897 and rs4647603 with the risk of prostate cancer in Galicia (NW Spain). Gene. 2018;679:126–132.
   PubMed Web of Science ®Google Scholar
• Guo X, Dong Z, Yamada S, et al. Association of Casp3 microRNA target site (1049216) SNP with the risk and progress of cervical squamous cell carcinoma. Int J Gynecol Cancer. 2017;27:206–213.
   PubMed Web of Science ®Google Scholar
• Deng B, Liu F, Luo L, et al. CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population. Tumour Biol. 2016;37:8985–8991.
   PubMedGoogle Scholar
• Hosgood HD 3rd, Baris D, Zhang Y, et al. Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol Oncol. 2008;26:148–151.
   PubMed Web of Science ®Google Scholar
• Yan S, Li YZ, Zhu XW, et al. HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk. Genet Mol Res. 2013;12:1561–1573.
   PubMed Web of Science ®Google Scholar